This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cardiovascular mortality is still excessively high, despite the considerable progress made in the prevention and treatment of cardiovasculardiseases. Although many cardiovascularriskfactors (such as arterial hypertension, hypercholesterolemia, diabetes, etc.),
Objectives To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 vs. 51.6 ± 14.7
We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% Prevalences of coronary disease (7.8% to 2.4%), and total cardiovasculardisease (11.3%
Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not well defined. This study aimed to evaluate the riskfactors associated with LV mass and subclinical coronary atherosclerosis, in an Asian population free of baseline cardiovasculardisease.
BackgroundThe relationship between resting heart rate (RHR) and the risk of end‐stage renal disease (ESRD) among those without cardiovasculardisease remains unclear. The risk of ESRD remained significantly elevated (HR, 1.32 [95% CI, 1.10–1.58]
Background Current clinical guidelines on cardiovasculardisease (CVD) do not specifically address the female population. The aim of this consensus is to know the opinion of a group of experts on the management of CVD in women. Results After two rounds, consensus in agreement was reached on 27 items (61.4%).
The human capital approach was used to estimate productivity losses from morbidity and premature mortality due to cardiovascular conditions.RESULTS:One in 3 US adults received care for a cardiovascularriskfactor or condition in 2020.
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovasculardisease, cognitive impairment, and frailty also share the following riskfactors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
Outcomes were body mass index, highdensity lipoprotein cholesterol, lowdensity lipoprotein cholesterol, fasting triglycerides, and the presence of hypertension (n=449), diabetes (n=66), metabolic syndrome (n=254), or coronary heart disease (n=25). The primary measure compared MBH with amygdala (MBH/amygdala).
Objective Observational studies show that hypertensive disorders of pregnancy (HDPs) are related to unfavourable maternal cardiovasculardisease (CVD) risk profiles later in life. to 1.38) per unit increase in the log odds of genetic liability to pre-eclampsia/eclampsia and gestational hypertension, respectively.
Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovasculardisease. White) to assess their CKM stages, finding the following breakdown: Stage 0 (no riskfactors) – 10.6% in Whites).
Pre-eclampsia and heart failure have common riskfactors, including hypertension, obesity and diabetes. It is not known whether heart failure increases the risk of pre-eclampsia. This study examines whether pregestational heart failure increases the risk of pre-eclampsia.
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. to 61% of the U.S.
Hypertensive disorders of pregnancy as a riskfactor for heart failure. BMI, body mass index; CV, cardiovascular; CVD, cardiovasculardisease; HELLP, haemolysis, elevated liver enzymes, low platelet count.
A substantial gap was found between the self-reports of cardiovasculardisease (CVD) by former players in the National Football League (NFL) and a "surprisingly high" prevalence of hypertension, with a "significant discrepancy between participants' awareness and observed disease prevalence," according to the findings.
Hypertension is a leading cause of morbidity and mortality worldwide and poses a major riskfactor for cardiovasculardiseases and chronic kidney disease.
Aims:Asian Americans experience disproportionate burdens of cardiovascularriskfactors and cardiovasculardisease (CVD). However, the trends in cardiovascularrisks in adults from different Asian ethnic backgrounds remain understudied.
Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovasculardisease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD riskfactors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.
Hypertension, Ahead of Print. Blood pressure guidelines serve as a beacon of best practice for the diagnosis and management of hypertension. The many cultural and societal differences in hypertensionriskfactors and management patterns across geographic regions support the need for geographically distinct international guidelines.
Control of dyslipidemia and diabetes, but not hypertension, reduces the association of HIV status with cardiovasculardisease (CVD), according to a study published online Jan. 16 in Clinical Infectious Diseases.
Background and objectives Hypertension is one of the most serious riskfactors and the leading cause of mortality in patients with cardiovasculardiseases (CVDs). It is necessary to accurately predict the mortality of patients suffering from CVDs with hypertension.
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascularriskfactors.
An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovasculardisease, and this prevalence is unchanged over time. said Michael Miedema, MD, MPH , director of the Nolan Family Center for Cardiovascular Health at MHIF and senior author of the research.
Here’s what you can expect at the biggest conference in cardiorenal metabolic health, the 19th Annual Cardiometabolic Congress (CMHC), DECODING THE CONSTELLATION of Cardiometabolic Health and RiskFactors. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.
Background High blood pressure (BP) is a major riskfactor for cardiovasculardisease (CVD). Adequate treatment of high BP should reduce the risk of CVD, but this association has seldom been assessed in a general population setting.
Background Left ventricular hypertrophy (LVH) is frequently seen in association with arterial hypertension and indicates poor prognosis. This study aimed to determine the prevalence of LVH and associated factors in a multiethnic population from Mauritius. to 1.75)), hypertension (3.01 (2.55 to 1.75)), hypertension (3.01 (2.55
Obesity, a major riskfactor for cardiovasculardisease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.
Hypertension is a major riskfactor for cardiovasculardisease (CVD), and a major contributor to global morbidity and mortality. Aprocitentan has been recently FDA-approved, marking a major milestone in hypertension management, offering hope for patients with difficult-to-treat hypertension.
BackgroundRING finger protein 213 (RNF213) p.R4810K is an established riskfactor for moyamoya disease and intracranial artery stenosis in East Asian people. Recent evidence suggests its potential association with extracranial cardiovasculardiseases, including pulmonary hypertension.
Background and aims Hypertension is a leading riskfactor for cardiovasculardisease. This study aimed to identify codelists used to define hypertension in studies that use EHRs and generate recommended codelists to support reproducibility and consistency. EHRs can be used for epidemiological research.
BACKGROUND:The relationship between marijuana use and cardiovascular health remains uncertain, with several observational studies suggesting a potential association with increased adverse atherosclerotic cardiovasculardisease (ASCVD) outcomes. Likewise, mean 10-year ASCVD risk scores (2.8% were current users. P=0.76; 79.8%
Hypertension, Ahead of Print. BACKGROUND:Hypertension is a major cardiovascularriskfactor, yet traditional care often results in suboptimal blood pressure (BP) control at the population level. We implemented a remote hypertension management program that monitored home BP and titrated medications per algorithm.
Hypertension, Ahead of Print. Hypertension is the primary modifiable riskfactor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide.
HTN elevated the incidence risk of major cardiovasculardisease by 2.16 Dyslipidemia and HTN were the most dominant riskfactors for myocardial infarction and stroke, respectively. The antihypertensive medications decreased the major cardiovasculardisease incidence estimates.
BackgroundAsian people in the United States have different sociodemographic and health‐related characteristics that might affect cardiovasculardisease (CVD) risk by ethnicity and birthplace. Providers should consider this heterogeneity in CVD riskfactors and establish tailored CVD prevention plans for Asian subgroups.
BACKGROUND:The focus for reducing hypertension-related cardiovasculardisease is the management of blood pressure. Participants were stratified by duration of recognized hypertension: normotensive (0 years), 5 years, 6 to 20 years, or 21+ years. Stroke, Volume 56, Issue 1 , Page 105-112, January 1, 2025.
Background:Hypertension (HTN) is a major riskfactor for cardiovasculardisease (CVD) and is the leading cause of morbidity and mortality globally, with a rise in prevalence in low and middle-income countries (LMIC). Circulation, Volume 150, Issue Suppl_1 , Page A4146960-A4146960, November 12, 2024. mmHg, respectively.
Hypertension, Volume 80, Issue 12 , Page 2581-2590, December 1, 2023. BACKGROUND:This study aimed to develop a risk-scoring model for hypertension among Africans.METHODS:In this study, 4413 stroke-free controls were used to develop the risk-scoring model for hypertension. for the training set and 64.6% (95% CI, 61.0–68.0)
Cancer and cardiovasculardisease represent the two leading causes of morbidity and mortality worldwide. However, this comes at a cost with more women developing diabetes, hypertension and coronary artery disease as they age. Women continue to enjoy a greater life expectancy than men.
IntroductionPatients with cognitive impairment often have a history of cardiovasculardisease (CVD) or multiple cardiovascularriskfactors (CRFs) such as hypertension, obesity, and hypercholesterolemia. Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023.
Hypertension is the leading modifiable riskfactor for cardiovasculardisease (CVD) in the US, affects 122 million adults, and is projected to exceed 180 million adults by 2050.
Background Hypertension is a silent killer that causes serious health issues in all parts of the world. It is riskfactor for cardiovasculardisease, stroke and kidney disease. Self-monitoring practice has been identified as an important component of hypertension management. 25 software for analysis.
Background The COVID-19 pandemic disrupted the continuing management of cardiovasculardisease (CVD) riskfactors in the population. Whether the COVID-19 pandemic increased, the SES gap in CVD riskfactors is unknown. The SES gap did not increase except for hypertension awareness.
This study sought to evaluate the prevalence of cardiovascularriskfactors, overt cardiovasculardisease and cardiac imaging abnormalities using cardiac magnetic resonance (CMR), in participants with normal LVEF on completion of trastuzumab±anthracycline therapy at least 5 years previously. years (range 5.9–10.8
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content